Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson’s Disease: A Network Meta-Analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson’s Disease: A Network Meta-Analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-04
DOI
10.1038/srep45865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of rasagiline in PD patients with mild cognitive impairment
- (2016) Daniel Weintraub et al. PARKINSONISM & RELATED DISORDERS
- Pharmacokinetic Properties and Tolerability of Rotigotine Transdermal Patch After Repeated-Dose Application in Healthy Korean Volunteers
- (2015) Bo-Hyung Kim et al. CLINICAL THERAPEUTICS
- Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial
- (2015) A. Antonini et al. EUROPEAN JOURNAL OF NEUROLOGY
- A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients
- (2015) P. Barone et al. EUROPEAN JOURNAL OF NEUROLOGY
- Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome:post hocanalysis of patients with early Parkinson’s disease with mild symptom severity
- (2015) Lars Timmermann et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
- (2015) Werner Poewe et al. LANCET NEUROLOGY
- New treatments for levodopa-induced motor complications
- (2015) Olivier Rascol et al. MOVEMENT DISORDERS
- Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease
- (2015) Thien Thien Lim et al. MOVEMENT DISORDERS
- Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease
- (2015) Robert A. Hauser et al. JAMA Neurology
- Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study
- (2015) Kara M. Smith et al. JAMA Neurology
- Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
- (2014) R. A. Hauser et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinsonâs disease: a thorough QT/QTc study
- (2014) Boaz Mendzelevski et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
- (2014) Masahiro Nomoto et al. JOURNAL OF NEUROLOGY
- Rotigotine vs ropinirole in advanced stage Parkinson's disease: A double-blind study
- (2014) Yoshikuni Mizuno et al. PARKINSONISM & RELATED DISORDERS
- Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: Post-hoc analyses from the ADAGIO trial
- (2014) Joseph Jankovic et al. PARKINSONISM & RELATED DISORDERS
- Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease
- (2013) Julián Solís-García del Pozo et al. Expert Opinion On Drug Safety
- Efficacy and safety of rasagiline as an adjunct to levodopa treatment in Chinese patients with Parkinson's disease: a randomized, double-blind, parallel-controlled, multi-centre trial
- (2013) Lina Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease
- (2013) Meghan R. Hennis et al. NEUROBIOLOGY OF DISEASE
- Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease
- (2013) A. Storch et al. NEUROLOGY
- Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
- (2013) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease
- (2012) François Viallet et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease
- (2011) F. Stocchi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials
- (2011) Cristina Sampaio et al. MOVEMENT DISORDERS
- The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study
- (2011) Hasmet A. Hanagasi et al. MOVEMENT DISORDERS
- Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial
- (2011) W. Poewe et al. NEUROLOGY
- Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial
- (2011) A. H. V. Schapira et al. NEUROLOGY
- Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease
- (2010) V. V. Myllylä et al. ACTA NEUROLOGICA SCANDINAVICA
- Effects of bromocriptine on Parkinsonism A nation-wide collaborative double-blind study
- (2010) Yasuo Toyokura et al. ACTA NEUROLOGICA SCANDINAVICA
- Ageing, neurodegeneration and Parkinson's disease
- (2010) J. V. Hindle AGE AND AGEING
- Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: An open-label study
- (2010) Laura Cif et al. MOVEMENT DISORDERS
- Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
- (2010) Robert A. Hauser et al. MOVEMENT DISORDERS
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)
- (2010) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial
- (2010) Karl Kieburtz et al. MOVEMENT DISORDERS
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study
- (2008) Fabrizio Stocchi et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More